Full-Time

Account Executive

Physician Sales

Updated on 8/21/2026

Akumin

Akumin

1,001-5,000 employees

Outsourced radiology and oncology services

Compensation Overview

$70k - $85k/yr

Philadelphia, PA, USA

Remote

Only candidates near north Philadelphia are eligible. The role may require 90–95% travel.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Sales & Account Management (1)
Required Skills
Sales
Marketing

Get referred to Akumin

See people who can refer or advise you

Requirements
  • A high school diploma or equivalent experience is required.
  • Demonstrated business acumen and understanding of the sales and physician space, including the reimbursement landscape.
  • Proven ability to successfully execute a territory development plan.
  • A proven track record of success in a competitive selling environment.
  • Exceptional communication and presentation skills.
Responsibilities
  • Increase order and scan volume across all modalities from referring providers in the assigned geographic territory to exceed budgeted same-store-growth, scan volume, and revenue commitments.
  • Analyze physician referral patterns to develop customer-level marketing plans, identify opportunities with existing referrers, and develop new referral channels.
  • Manage the assigned expense budget.
  • Cultivate relationships with strategic referrers, identify key customer drivers, ensure customer needs are met, and communicate service deficiencies to the Operations Team.
  • Prospect and target new referrers based on market trends and conditions, using consultative selling to uncover unmet needs and competitive takeaways.
  • Analyze marketed account referral patterns, strategically plan field time and actions, and monitor variances and trends in the existing referral base.
  • Work with operations and management to determine possible causes for changes in referral patterns.
  • Work with territory Physician Sales and Operations leadership to establish customer and territory plans that deliver budgeted growth, scan volume, target, and revenue commitments.
  • Identify risks to the referral base and implement community outreach programs, including territory-level educational campaigns, health fairs, and other events.
  • Participate in operational meetings, provide status updates, identify areas for strategic Physician Sales engagement, and participate in Quarterly Business Reviews with key strategic accounts.
  • Perform other duties as assigned by management.
Desired Qualifications
  • A bachelor's degree or equivalent experience.
  • Two years of physician sales and marketing experience in a healthcare environment.
  • Prior imaging and/or oncology experience.

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Get referred to Akumin

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Plantation renovation with United Imaging signals continued capital investment.
  • June 2026 MHI facility supports high-volume production for MRI, PET, and LINAC units.
  • Akumin now markets a simpler balance sheet after 2024 bankruptcy completion.

What critics are saying

  • January 2025 data-breach class action demands $5 million and injunctive relief.
  • Private ownership under Stonepeak concentrates control and limits exit flexibility for employees.
  • Any AXIS production delay jeopardizes 2026 growth and validates competitors' mobile-imaging offerings.

What makes Akumin unique

  • Stonepeak owns Akumin after February 2024 deleveraging and delisting.
  • Akumin combines fixed-site imaging, mobile solutions, and oncology across 800-plus partners.
  • June 2026 MHI JV manufactures relocatable AXIS clinics in New Berlin.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

31%

1 year growth

31%

2 year growth

31%
Business Wire
Jun 23rd, 2026
Akumin and CGS Premier launch joint venture to scale relocatable imaging and oncology clinics

Akumin, a provider of diagnostic imaging and oncology solutions, has partnered with Wisconsin-based manufacturer CGS Premier to form Mobile Healthcare Innovations (MHI), a joint venture focused on producing Akumin AXIS relocatable clinics. The partners have opened an 85,400-square-foot facility in New Berlin, Wisconsin, designed for high-volume production. Akumin AXIS units are self-contained imaging and oncology clinics with pre-installed MRI, PET or LINAC technology. The venture aims to address growing demand for imaging and oncology services across the United States. Akumin operates one of the nation's largest networks of fixed-site radiology centres and mobile solutions, partnering with over 800 hospitals and physician groups. The investment supports local job creation whilst positioning Akumin for continued expansion.

Radiology Business
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

CanTech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal